Description
Quantitative determination of the expression of the chimeric oncogene BCR-ABL by PCR, which plays a key role in the pathogenesis of chronic myeloid leukemia (CML), is currently recognized as the main method for molecular diagnostics and monitoring of the disease course.
Period of execution
Within 10 days. The specified time does not include the day of biomaterial collection
Biomaterial type